These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 37409628)
1. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI. Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628 [TBL] [Abstract][Full Text] [Related]
2. Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors. Ding K; Zhang X; Zhao J; Zuo H; Bi Z; Cheng H Integr Cancer Ther; 2020; 19():1534735420938450. PubMed ID: 32683997 [No Abstract] [Full Text] [Related]
3. The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values. Yao S; Ding K; Liu S; Zhang Q; Li W; Tang L; Yu S; Pang L; Yin X; Cheng H Integr Cancer Ther; 2022; 21():15347354221140498. PubMed ID: 36419389 [TBL] [Abstract][Full Text] [Related]
4. Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention. Pang L; Bi Z; Jing Y; Yin X; Zhang X; Yao S; Zhao J; Cheng H Am J Cancer Res; 2021; 11(11):5415-5427. PubMed ID: 34873469 [TBL] [Abstract][Full Text] [Related]
5. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer. Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458 [TBL] [Abstract][Full Text] [Related]
6. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study. Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study. Chen BT; Jin T; Patel SK; Ye N; Ma H; Wong CW; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Sedrak MS; Vazquez J; Katheria V; Dale W Breast Cancer Res Treat; 2019 Jul; 176(1):181-189. PubMed ID: 30989462 [TBL] [Abstract][Full Text] [Related]
8. Cognitive Dysfunction and Neurophysiologic Mechanism of Breast Cancer Patients Undergoing Chemotherapy Based on Resting State Functional Magnetic Resonance Imaging. Bai X; Zheng J; Zhang B; Luo Y World Neurosurg; 2021 May; 149():406-412. PubMed ID: 33096278 [TBL] [Abstract][Full Text] [Related]
9. The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors. Zhang X; Yao S; Wang M; Yin X; Bi Z; Jing Y; Cheng H J Oncol; 2022; 2022():1012813. PubMed ID: 35712124 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors. Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947 [TBL] [Abstract][Full Text] [Related]
11. The rs-fMRI study of effects of fornix and hippocampus-related brain function after the transcallosal interforniceal approach. Zhu J; Zhao YP; Zhang YQ Brain Res Bull; 2019 Aug; 150():207-215. PubMed ID: 31128251 [TBL] [Abstract][Full Text] [Related]
12. Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors. Hsiao CP; Goto T; Von Ah D; Saligan LN Semin Oncol Nurs; 2024 Oct; 40(5):151721. PubMed ID: 39198096 [TBL] [Abstract][Full Text] [Related]
13. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study. Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321 [TBL] [Abstract][Full Text] [Related]
14. In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors". Zarrella GV; Braun SE Integr Cancer Ther; 2023; 22():15347354231191706. PubMed ID: 37605802 [No Abstract] [Full Text] [Related]
15. Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis. Tong T; Lu H; Zong J; Lv Q; Chu X Breast Cancer; 2020 Sep; 27(5):893-902. PubMed ID: 32301096 [TBL] [Abstract][Full Text] [Related]
16. Re: Response to In regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors". Cheng H; Ding K; Yao S Integr Cancer Ther; 2023; 22():15347354231191715. PubMed ID: 37551862 [No Abstract] [Full Text] [Related]
17. Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels. Pang L; Li W; Yao S; Jing Y; Yin X; Cheng H Cancer Med; 2023 May; 12(10):11806-11815. PubMed ID: 36965094 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced functional brain abnormality in colorectal cancer patients: a resting-state functional magnetic resonance imaging study. Liu S; Guo Y; Ni J; Yin N; Li C; Pan X; Ma R; Wu J; Li S; Li X Front Oncol; 2022; 12():900855. PubMed ID: 35924154 [TBL] [Abstract][Full Text] [Related]
19. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer. Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315 [TBL] [Abstract][Full Text] [Related]
20. Aberrant Spontaneous Brain Activity and its Association with Cognitive Function in Non-Obese Nonalcoholic Fatty Liver Disease: A Resting-State fMRI Study. Xu JL; Gu JP; Wang LY; Zhu QR; You NN; Li J; Li J; Shi JP J Integr Neurosci; 2023 Jan; 22(1):8. PubMed ID: 36722230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]